GLP-1 drugs , or glucagon-like peptide-1 analogs , represent a substantial shift in how we approach type 2 diabetes . These new therapies work by mimicking the body’s inherent GLP-1 hormone , which https://antonnrze319323.bligblogging.com/42677353/glp-1-a-significant-advance-in-blood-sugar-treatment